Genomics-based anti-cancer drug discovery - Preface

被引：0
|
作者：
Devi, GR [1 ]
机构：
[1] AVI BioPharma Inc, Canc Endocrine Program, Corvallis, OR 97333 USA
来源：
CURRENT PHARMACEUTICAL BIOTECHNOLOGY | 2004年 / 5卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Genomics-based discovery of macrolide glycosyltransferase from Bacillus sp.
    Kim, Won-Gon
    Park, Ji Yeong
    Kim, Hyun Ju
    NEW BIOTECHNOLOGY, 2014, 31 : S178 - S178
  • [42] Genomics-based approach towards the discovery of a lipopeptide from Herpetosiphon aurantiacus
    Natesan, L.
    Nett, M.
    Koenig, G.
    PLANTA MEDICA, 2010, 76 (12) : 1231 - 1231
  • [43] Genomics-based individualized cancer therapy - Hype or hope?
    Froehling, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 228 - 228
  • [44] Apoptosis and Anti-cancer Drug Discovery: The Power of Medicinal Fungi and Plants
    Wong, Jack Ho
    Sze, Stephen Cho Wing
    Ng, Tzi Bun
    Cheung, Randy Chi Fai
    Tam, Chit
    Zhang, Kalin Yanbo
    Dan, Xiuli
    Chan, Yau Sang
    Cho, William Chi Shing
    Ng, Charlene Cheuk Wing
    Waye, Mary Miu Yee
    Liang, Weicheng
    Zhang, Jinfang
    Yang, Jie
    Ye, Xiuyun
    Lin, Juan
    Ye, Xiujuan
    Wang, Hexiang
    Liu, Fang
    Chan, David Wai
    Ngan, Hextan Yuen Sheung
    Sha, Ou
    Li, Guohui
    Tse, Ryan
    Tse, Tak Fu
    Chan, Helen
    CURRENT MEDICINAL CHEMISTRY, 2018, 25 (40) : 5613 - 5630
  • [45] Identification of NAPRT Inhibitors with Anti-Cancer Properties by In Silico Drug Discovery
    Ghanem, Moustafa S.
    Caffa, Irene
    Del Rio, Alberto
    Franco, Jorge
    Parenti, Marco Daniele
    Monacelli, Fiammetta
    Cea, Michele
    Khalifa, Amr
    Nahimana, Aimable
    Duchosal, Michel A.
    Ravera, Silvia
    Bertola, Nadia
    Bruzzone, Santina
    Nencioni, Alessio
    Piacente, Francesco
    PHARMACEUTICALS, 2022, 15 (07)
  • [46] IDENTIFYING GENOMICS-BASED THERAPEUTIC TARGETS IN LUNG CANCER
    Thomas, R.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S10 - S10
  • [47] Novel drug resistant CDX models for anti-cancer drugs discovery
    Dai, Hai-Ting
    Bing, Tie-Jun
    An, Zhi-Da
    Yang, Jie
    Pang, Tian-Yu
    Gao, Jia-Wei
    Bo, Yun-Yi
    Yu, Wen-Jen
    CANCER RESEARCH, 2024, 84 (06)
  • [48] The Use and Refinement of Rodent Models in Anti-cancer Drug Discovery: A Review
    Curwen, Jon O.
    Wedge, Stephen R.
    ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2009, 37 (02): : 173 - 180
  • [49] Drug repositioning and diversification strategy for discovery of compounds with anti-cancer activity
    Gibson, Daniel
    Chapa, Matthew
    Rowland, Bradley
    Bateman, David
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [50] Fusing Artificial Intelligence and Machine Learning for Anti-Cancer Drug Discovery
    Adamopoulos, Christos
    Papavassiliou, Kostas A.
    Papavassiliou, Athanasios G.
    CANCERS, 2024, 16 (20)
12345